In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12

Infection and Immunity

Volumn 66, Issue 1, 1998, Pages 65-69

  Brieland, J K ^a,c   Remick, D G ^b   Legendre, M L ^b   Engleberg, N C ^b   Fantone, J C ^c  

^a Unit for Laboratory Animal Medicine   (United States)

^b Department of Pathology ^*  (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; IMMUNOMODULATION; INOCULATION; INTERFERON PRODUCTION; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031964336     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.1.65-69.1998     Document Type: Article

References (57)

1. Allendoerfer, R., G. P. Boivin, and G. S. Deepe, Jr. 1997. Modulation of immune responses in murinc pulmonary histoplasmosis. J. Infect. Dis. 175: 905-914.
2. Bamford, R. N., A. J. Grant, J. D. Burton, C. Peters, G. Kurjs, C. K. Goldman, J. Brennan, E. Roesslcr, and T. A. Waldmann. 1994. The interleukin (IL) 2 receptor β-chain is shared by IL-2 and a cytokine provisionally designated IL-T that stimulates T cell proliferation and the induction of lymphokinc activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940-1944.
3. Bermudei, L. E., M. Vu, and L. S. Young. 1995. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect. Immun. 63:4099-4104.
4. Berlagnolli, M. M., B. Y. Lin, D. Young, and S. H. Herrmann. 1992. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149:3778-3783.
5. Biron, C. A, and R. T. Gazzinelli. 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease out-come. Curr. Opin. Immunol. 7:485-496.
6. Blanchard, D. K., J. Y. Djeu, T. W. Klein, H. Friedman, W. E. Stewart 2nd, and W. E. Stewart. 19SS. Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J. Leukocyte Biol. 43:429-135.
7. Blanchard, D. K., II. Friedman, T. W. Klein, and J. Y. Djeu. 1989. Induction of interferon gamma and tumor necrosis factor by Legionella pneumophila. Augmentation of human neutrophil bactericidal activity. J. Leukocyte Biol. 45:538-545.
8. Blander, S. J., and M. A. Hornitz. 1991. Vaccination with Legionella pneumophila membranes induces cell mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila. J. Clin. Invest. 87:1054-1059.
9. Breiman, R. F. 1993. Modes of transmission in epidemic and noncpidemic Legionella infection: directions for further study, p. 30-35. In J. M. Barbaree, R. F. Breiman, and A. P. Duflour (ed.), Legionella: current status and emerging perspectives. American Society for Microbiology, Washington, D.C.
10. Brieland, J., P. Freeman, R. Kunkel, C. Chrisp, M. Hurley, J. Fantone, and C. Englcbcrg. 1994. Replicative Legionella pneumophila lung infection in intratrachcally inoculated A/J mice. A murine model of human Legionnaires' disease. Am. J. Pathol. 145:1537-1546.
11. Brieland, J. K., L. A. Heath, G. B. Huffnagle, D. G. Kemick, M. S. McClain, M. C. Hurley, R. K. Kunkel, J. C. Fantone, and N. C. Engleberg. 1996. Humoral immunity and regulation of intrapulmonary growth of Legionella pneumophila in the immunocompetent host. J. Immunol. 157:5002-5008.
12. Brieland, J. K., D. G. Rcmick, P. T. Freeman, M. C. Hurley, J. C. Fantone, and N. C. Engleberg. 1995. In vivo regulation of replicativc Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect. Immun. 63:3253-3258.
13. Burton, J. I)., R. N. Bamford, C. Peters, A. J. Grant, G. Kurys, C. K. Goldman, J. Brennan, E. Rocssler, and T. A. VValdmann. 1994. A lymphokinc, provisionally designated intcrlcukin T and produced by a human adult T cell leukemia line, stimulates T cell proliferation and induction of lymphokinc-activatcd killer cells. Proc. Natl. Acad. Sci. USA 91:4935-4939.
14. Byrd, T. F., and M. A. Ilonvitz. 19S9. Interferon gamma- activated human monocytes downregulate transfcrrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 83:1457-1465.
15. Byrd, T. F., and M. A. Horwitz. 1990. Interferon gamma-activated human monocytes downregulate the intracellular concentration of fcrritin: a potential new mechanism for limiting iron availability to Legionella pneumophila and subsequently inhibiting intracellular multiplication. Clin. Res. 38:481. (Abstract.)
16. Carson, W. E., and M. A. Caliguiri. 1996. Intcrlcukin 15: a potential player during the innate immune responses to infection. Exp. Parasitol. 84:291-294.
17. Carson, W. E., J. G. Giri, M. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eiscnmann, K. Grabstein, and M. A. Caligiuri. 1994. Intcrlcukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Mcd. 180:1395-1403.
18. Carson, V. E., M. E. ROSS, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of IL-15 by activated human monocytcs is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Invest. 96:2578-2582.
19. Chan, S. H., B. Pcrussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trincliieri. 1991. Induction of IFN-gamma production by natural killer cell stimulatory factor: characterization of the rcsponder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
20. Conlan, J. W., A. Baskenille, and L. A. Asrmorth. 1986. Separation of Legionella pneumophila proteascs and purification of a protease which produces lesions like those of Legionnaires' disease in guinea-pig lung. J. Gen. Microbiol. 132:1565-1574.
21. Conlan, J. V, A. Williams, and L. A. Ashworth. 19S8. In vivo production of a tissue-destructive protease by Legionella pneumophila in the lungs of experimentally infected guinea pigs. J. Gen. Microbiol. 134:143-149.
22. Edelstein, P. II. 1981. Improved semiselectivc medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens. J. Clin. Microbiol. 14:298-303.
23. Eisenstein, T., and II. Friedman. 1985. Immunity to Legionella, p. 159-169 In S. M. Katz (ed.), Legionellosis, vol. 2. CRC Press, Boca Raton, Fla.
24. Eskandari, M. K., D. T. Ngujen, S. L. Kunkel, and D. G. Remick. 1990. Wchi 164 subclone 13 assay for TNF: sensitivity, specificity and reliability. Immunol. Invest. 19:69-79.
25. Feeley, J. C., R. J. Gibson, G. W. German, N. C. Langford, J. K. Raheed, R. C. Mackel, and W. B. Baine. 1979. Charcoal-yeast extract agar: primary medium for Legionella pneuniophila. J. Clin. Microbiol. 10:437-441.
26. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515-2524.
27. Fricdman, II., R. Widen, T. Klein, L. Searls, and K. Cabrian. 1984. Legionella pnciimophita induced blastogenesis of murine lymphoid cells in vitro. Infect. Immun. 43:314-319.
28. Friedman, H., R. Widen, I. Lee, and T. Klein. 1983. Cellular immunity to Legionella pneuniophila in guinea pigs assessed by direct and indirect migration inhibition reactions in vitro. Infect. Immun. 41:1132-1137.
29. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115-6119.
30. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
31. Greenberger, M. J., S. L. Kunkel, R. M. Strieter, N. W. Lukacs, J. Bramson, J. Gauldie, F. L. Graham, M. Hilt, J. M. Danforth, and T. J. Standiford. 1996. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol. 157:3006-3012.
32. Gubler, U., A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motjka, N. Nabavi, A. G. Wolitzy, P. M. Quinn, P. C. Familletti, and M. K. Gately. 1991. Coexprcssion of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88:4143-4147.
33. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant intcrleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1509.
34. Horwitz, M. A. 1983. The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J. Exp. Med. 158:2108-2126.
35. Honvitz, M. A. 1983. Cell-mediated immunity in Legionnaires' disease. J. Clin. Invest. 71:1686-1697.
36. Honvitz, M. A. 1984. Phagocytosis of Legionnaires' disease bacterium (Legionella pneiimophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell 36:27-33.
37. Horwitz, M. A., and S. C. Silverstein. 19SO. Legionnaires' disease bacterium (Legionella pneiimophila) multiplies intracellularly in human monocytes. J. Clin. Invest. 66:441-450.
38. Jullien, D., P. A. Sieling, K. Uyemura, N. D. Mar, T. H. Rea, and R. L. Modlin. 1997. IL-15, an immunomodulator of T cell responses in intracellular infection. J. Immunol. 158:800-806.
39. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. London, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biplogic effects on human lymphocytes. J. Exp. Med. 170:827-845.
40. Kobayashi, K., T. Kasama J. Yamazaki, M. Hosaka, T. Katsura, T. Mochizuki, K. Soejima, and R. M. Nakamura. 1995. Protection of mice from Myeobaeterium avium infection by recombinant interleukin-12. Antimicrob. Agents Chemother. 39:1369-1371.
41. Ma, X., A. Aste-Amezaga, and G. Trichieri. 1996. Regulation of interleukin-12 production. N.Y. Acad. Sci. 795:13-25.
42. Matsiota-Bemard, P., C. Lefebre, M. Scdqui, P. Cornillet, and M. Guenounou. 1993. Involvement of tumor necrosis factor alpha in intracellular mul-tiplication of Legionella pneumophila in human monocytes. Infect. Immun. 61:4980-4983.
43. McDade, J. E., C. C. Shepard, D. W. Fraser, T. R. Tsai, M. A. Redus, and W. R. Dovvdlc. 1977. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N. Engl. J. Med. 297:1197-1203.
44. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Cause, B. R. Hubbard, M. K. Gately, and F. D. Finkclman. 1994. Effects of IL-12 in in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047-1056.
45. Nash, T. W., D. M. Libby, and M. A. Horwitz. 1984. Interaction between the Legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines and hydrocortisone. J. Clin. Invest. 74:771-782.
46. Park, D. R., and S. J. Skerrett. 1996. IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-γ. Differential responses of blood monocytes and alveolar macrophages. J. Immunol. 157:2528-2538.
47. + T lymphocytes and NK cells. J. Immunol. 149:3495-3502.
48. Robertson M. J., R. J. Soiffer, S. F. Wolf, T. J. Manley, C. Donahue, D. Young, S. H. Herrmann, and J. Ritz. 1992. Response of human natural killer cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175:779-788.
49. Stein-Streilein, J., and J. Gufiee. 1986. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136:1435-1441.
50. Stern, A. S., F. J. Podlaski, J. D. Hulraes, Y. C. Pan, P. M. Quinn, A. G. Wolitzky, P. C. Familktti, D. L. Stremlo, T. Truitt, and R. Chizzonite. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87:6808-6812.
51. Stevenson, M. M., M. F. Tam, S. F. Wolf, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:2545-2556.
52. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.
53. Takeuchi, E., H. Yanagawa, S. Yano, T. Haku, and S. Sone. 1996. Induction of interleukin 15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms. Jpn. J. Cancer Res. 87:1251-1258.
54. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and CB-17 mice: reversal by IFN-γ. J. Immunol. 152:1883-1887.
55. Wagner, R. D., H. Steinberg, J. F. Brown, and C. J. Czuprynski. 1994. Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microb. Pathog. 17:175-186.
56. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, L. Azzoni, R. M. Hewick, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and NK cells. J. Immunol. 146:3074-3081.
57. Yamamoto, Y., T. W. Klein, C. Newton, and H. Friedman. 1992. Differing macrophage and lymphocyte roles in resistance to Legionella pneumophila infection. J. Immunol. 148:584-589.